,
your personalized virtual assistant to find clinical trials. Go head, 
Richard M. Stone, M.D.
Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 Dana-Farber/Harvard Cancer Center at Dana ...Boston, Massachusetts - 02115 (617-632-4001) |
- CLINICAL TRIALS 8
- CONDITIONS12
- INTERVENTIONS24
- SINCE1984
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
August 2010 - January 2015
RAD001 in Combination With PKC412 in Patients With Relapsed Refractory or Poor Prognosis AML or MDS
January 2009 - January 2011
Daunorubicin Cytarabine and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
April 2008 - July 2013
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
June 2008 - December 2010
Genetic Study of Patients With Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes or Multiple Myeloma
June 1984 - July 2005
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
June 2008 - December 2018
Collecting and Storing Blood Bone Marrow and Other Samples From Patients With Acute Leukemia Chronic Leukemia or Myelodysplastic Syndromes
May 1996 -
A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
November 2007 - November 2010
Lymphoma
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphoid
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Myeloproliferative Disorders
Placebo
Laboratory Biomarker Analysis
Plerixafor
Gene Expression Analysis
Lenalidomide
Cytarabine
Etoposide
Rad001
Bortezomib
Polymerase Chain Reaction
Dna Methylation Analysis
Reverse Transcriptase-Polymerase Chain Reaction
Dna Analysis
Daunorubicin Hydrochloride
Midostaurin
Mutation Analysis
G-Csf
Mitoxantrone
Biologic Sample Preservation Procedure
High Performance Liquid Chromatography
Pkc412
Cytogenetic Analysis
Cordycepin Plus Pentostatin
Chromosomal Translocation Analysis
